In Conversation With: BGF’s Dennis Atkinson

Why It Matters

BGF’s long‑term capital and partnership approach strengthens the UK’s deep‑tech pipeline, reducing reliance on foreign funding and boosting domestic economic growth. By targeting the productisation gap, BGF improves the fundability of scale‑up candidates, driving sustainable job creation and export potential.

Key Takeaways

• BGF has deployed ~£5bn ($6.3bn) into 650+ UK firms
• Deeptech, life sciences, and advanced materials are UK’s top growth sectors
• Long‑term, flexible capital helps founders bridge tech breakthroughs to market
• Scaling productisation, not just innovation, determines fundability at scale

Pulse Analysis

The Business Growth Fund’s strategy reflects a broader shift in Europe toward patient capital that balances financial returns with ecosystem development. By committing roughly $6.3 billion across more than 650 companies, BGF not only supplies equity but also embeds operational expertise, addressing the notorious "valley of death" where many UK deep‑tech ventures stall. This model contrasts with traditional venture capital’s shorter horizons, offering founders the runway needed to refine prototypes, navigate regulatory pathways, and build repeatable sales processes.

UK innovation remains world‑class, especially in deep‑tech, life sciences, and advanced materials, yet the transition from laboratory breakthrough to market‑ready product often falters. Atkinson points to the missing "product layer"—the blend of engineering, design, and go‑to‑market strategy that converts scientific merit into revenue. BGF’s focus on companies that demonstrate early, repeatable customer traction helps bridge this gap, ensuring that technical excellence is matched by commercial clarity. This emphasis aligns with government priorities to boost high‑value exports and create resilient, high‑paying jobs.

Looking ahead, the fund’s emphasis on long‑term, partnership‑driven capital could reshape the UK’s scale‑up landscape. As domestic investors increasingly recognize the value of patient money, the reliance on overseas financing may diminish, keeping more upside within the British economy. Moreover, BGF’s geographic diversification spreads growth beyond London, fostering regional tech clusters that can attract talent and ancillary services. In a competitive global market, such an ecosystem—where deep research meets disciplined execution—positions the UK to maintain its edge in next‑generation technologies.